![]() Avid Bioservices Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 1981 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Saint-Quentin-Fallavier, FR HQ | Locations Tustin, US HQ | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 2453% increase | Employees 21114% increase | Employees 58415% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 649.4 m | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) £95.9m (FY, 2015) | Revenue (est.) $139.9m (FY, 2024) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods £43.1m (FY, 2015) | Cost of goods $132.6m (FY, 2024) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit £52.8m (FY, 2015) | Gross profit $7.3m (FY, 2024) | Gross profit $561.3m (FY, 2025) |
Net income | Net income N/A | Net income ($140.8m) (FY, 2024) | Net income ($27.1m) (FY, 2025) |

Avid Bioservices, formerly Peregrine Pharmaceuticals, is a biopharmaceutical company.
View company
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company